2021
DOI: 10.2139/ssrn.3840280
|View full text |Cite
|
Sign up to set email alerts
|

Ethical, Legal, and Social Issues in the Earth BioGenome Project

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 18 publications
0
5
0
Order By: Relevance
“…In reality, in-depth monitoring can inflict unacceptable damage on fragile ecosystems, illustrating the need for careful study design, and technology that minimizes harm. Any project so broad in scope raises complicated ethical, legal, and social issues that must be carefully addressed ( 144 ). The potential for discovery in such rich datasets, extending far beyond genomics, encapsulates the vision of a more extensive, inclusive, Darwinian approach to genomics.…”
Section: Discussionmentioning
confidence: 99%
“…In reality, in-depth monitoring can inflict unacceptable damage on fragile ecosystems, illustrating the need for careful study design, and technology that minimizes harm. Any project so broad in scope raises complicated ethical, legal, and social issues that must be carefully addressed ( 144 ). The potential for discovery in such rich datasets, extending far beyond genomics, encapsulates the vision of a more extensive, inclusive, Darwinian approach to genomics.…”
Section: Discussionmentioning
confidence: 99%
“…To accomplish these goals, the EBP was established as an international network-of-networks: organizations that specialize in sample acquisition and vouchering; technology centers for sequencing, assembly, and annotation; and affiliated projects with deep expertise with specific taxonomic groups, biomes, and ecosystems ( Box 1 ). In addition, the EBP develops ethical standards for project participation, data sharing, access and benefit sharing of intellectual property derived from whole-genome sequencing [see Sherkow et al., this issue ( 15 )], and promotes programs for diversity, equity, inclusion, and justice among the project’s participants. The EBP Member Institutions and Affiliated Projects are committed to open data access and compliance with the principles of Access and Benefits Sharing under the Convention on Biological Diversity and the Nagoya Protocol ( 16 ).…”
Section: Organization and Governancementioning
confidence: 99%
“…The EBP’s Committee on Ethical, Legal, and Social Issues (ELSI), established in 2020, makes recommendations to the EBP Working Group on legal obligations relating to the Nagoya Protocol on Access and Benefit Sharing; ethical considerations relating to collection of samples, societal concerns, and biosecurity; and collaboration standards (e.g., sample information, digital sequence information, intellectual property, authorship and publication guidelines). The committee’s outline of the ELSI issues facing the EBP can be found in this issue ( 15 ). A Committee on Diversity, Equity, Inclusion, and Justice (DEIJ) was approved recently by the EBP Working Group.…”
Section: Organization and Governancementioning
confidence: 99%
“…Therefore, the recognition, inclusion, participation of IPLCs and the fair and equitable distribution of bene ts are of crucial importance to the success of the biodiversity genomics research community. There is a fraught history of IPLC samples and aTK being unethically accessed, utilized and Intellectual Property (IP) rights being used to appropriate the value of genetic resources without the appropriate consent or the equitable sharing of bene ts 28,29,30,31 . Research carried on genetic resources and the associated data can result in inventions that could be eligible for IP protection, and negotiating and granting access to genetic resources for research or commercial uses could also raise IP questions 31,32 .…”
Section: Introductionmentioning
confidence: 99%
“…There is a fraught history of IPLC samples and aTK being unethically accessed, utilized and Intellectual Property (IP) rights being used to appropriate the value of genetic resources without the appropriate consent or the equitable sharing of bene ts 28,29,30,31 . Research carried on genetic resources and the associated data can result in inventions that could be eligible for IP protection, and negotiating and granting access to genetic resources for research or commercial uses could also raise IP questions 31,32 . Many international fora [33][34][35][36] , including the Convention on Biological Diversity's Nagoya Protocol 16 , codify fair and equitable bene t-sharing from the access and use of genetic resources for the purposes of research and development when partnering with IPLCs.…”
Section: Introductionmentioning
confidence: 99%